CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,110.00
+50.00 (1.63%)
At close: Sep 4, 2026

CTCBIO Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
131,539123,769119,877137,878165,206140,318
Other Revenue
-0-0-0-0-0-0
131,539123,769119,877137,878165,206140,318
Revenue Growth
17.21%3.25%-13.06%-16.54%17.74%7.91%
Cost of Revenue
78,78173,81070,64495,309111,150107,228
Gross Profit
52,75849,95949,23242,57054,05633,090
Selling, General & Admin
38,79342,17248,28041,89437,19131,962
Research & Development
1,3141,7853,5582,6392,4143,090
Amortization of Goodwill & Intangibles
63.4466.1781.9396.74296.67414.05
Other Operating Expenses
438.49270.06317.14264.6208.57231.86
Operating Expenses
41,40943,70954,24647,14842,82636,027
Operating Income
11,3496,250-5,014-4,57811,230-2,938
Interest Expense
-2,292-2,317-2,846-3,244-2,895-3,647
Interest & Investment Income
302.46307.85520.97725.08251.11118.76
Currency Exchange Gain (Loss)
-567.4-1,382996.6641.68-470.14-533.35
Other Non Operating Income (Expenses)
-180.8366.551,771689.17-2,3741,952
EBT Excluding Unusual Items
8,6122,925-4,571-6,3675,741-5,047
Gain (Loss) on Sale of Investments
---186.4-201.64-320.2-708.55
Gain (Loss) on Sale of Assets
398.59321.68137.86264.89-40.551.28
Asset Writedown
-271.03-268.5-689.52-9,411-5,181-1,337
Other Unusual Items
----0.01-595.12
Pretax Income
8,7392,978-5,309-15,715199.42-7,687
Income Tax Expense
1,159-289.6-102.59-126.83-4,504291.74
Earnings From Continuing Operations
7,5803,268-5,206-15,5884,704-7,978
Earnings From Discontinued Operations
-66.73-27.15-14.05---
Net Income to Company
7,5133,241-5,220-15,5884,704-7,978
Minority Interest in Earnings
-----660.21
Net Income
7,5133,241-5,220-15,5884,704-7,318
Net Income to Common
7,5133,241-5,220-15,5884,704-7,318
Net Income Growth
------
Shares Outstanding (Basic)
242424242422
Shares Outstanding (Diluted)
242424242422
Shares Change
0.59%-0.16%0.16%0.38%7.17%11.67%
EPS (Basic)
313.12135.54-218.00-651.97197.49-329.29
EPS (Diluted)
313.12135.54-218.00-652.00197.00-329.29
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,1873,5972,3576,33115,0514,783
Free Cash Flow Per Share
299.51150.4398.42264.80631.92215.23
Gross Margin
40.11%40.37%41.07%30.88%32.72%23.58%
Operating Margin
8.63%5.05%-4.18%-3.32%6.80%-2.09%
Profit Margin
5.71%2.62%-4.35%-11.31%2.85%-5.21%
Free Cash Flow Margin
5.46%2.91%1.97%4.59%9.11%3.41%
EBITDA
17,73412,781891.051,36817,9363,344
EBITDA Margin
13.48%10.33%0.74%0.99%10.86%2.38%
D&A For EBITDA
6,3856,5325,9055,9476,7066,282
EBIT
11,3496,250-5,014-4,57811,230-2,938
EBIT Margin
8.63%5.05%-4.18%-3.32%6.80%-2.09%
Effective Tax Rate
13.27%-----
Advertising Expenses
-1,0611,1751,055636.46722.54